Page 288 - Read Online
P. 288

Butt et al. Hepatoma Res 2016;2:279-86                               Hepatoma Research
           DOI: 10.20517/2394-5079.2016.08
                                                                                                  www.hrjournal.net
            Original Article                                                                    Open Access


           Is transarterial embolization a valuable

           treatment option for spontaneous rupture

           of hepatocellular carcinoma: experience

           from a tertiary care hospital of South-Asia



           Amna Subhan Butt , Saeed Hamid , Nazish Butt , Fatima Sharif , Tanveer Ul Haq , Wasim Jafri 1
                                         1
                                                                                3
                            1
                                                                  2
                                                    1
           1 Section of Gastroenterology, Department of Medicine, The Aga Khan University, Karachi 74800, Pakistan
           2 The Aga Khan University, Karachi 74800, Pakistan
           3 Department of Radiology, The Aga Khan University, Karachi 74800, Pakistan
           Correspondence to: Dr. Amna Subhan Butt, Section of Gastroenterology, Department of Medicine, The Aga Khan University Hospital, Stadium
           Road, Karachi 74800, Pakistan. E-mail: amna.subhan@aku.edu
           How to cite this article: Butt AS, Hamid S, Butt N, Sharif F, Haq TU, Jafri W. Is transarterial embolization a valuable treatment option for
           spontaneous rupture of hepatocellular carcinoma: experience from a tertiary care hospital of South-Asia. Hepatoma Res 2016;2:279-86.


                                         ABSTRACT
            Article history:              Aim: Transarterial embolization (TAE) has been found beneficial in treatment of ruptured
            Received: 04-04-2016          Hepatocellular carcinoma (HCC) in earlier studies. So far no data is available from Pakistan.
            Accepted: 02-08-2016          The aim of this study was to evaluate clinicopathological characteristics, outcomes of patients
            Published: 21-10-2016         presented with spontaneously ruptured, unresectable HCC treated with or without TAE and
                                          to evaluate the factors associated with 30-day mortality. Methods: This was a cross sectional
            Key words:                    study.  Patients  ≥  18  years  old,  presented  with  spontaneous  rupture  of  unresectable  HCC,
            Ruptured hepatocellular carcinoma,   were evaluated. The outcome measures were control of bleeding, in-hospital mortality, 30-
            transarterial embolization,   day mortality and factors associated with 30-days mortality. Results: Out of 850 patients,
            Pakistan                      24 patients were diagnosed with spontaneously ruptured HCC. Mean age was 58.29 ± 15.26
                                          years. A total of 11 (45.8%) patients were treated conservatively and 13 (54.2%) underwent
                                          TAE. Control of bleeding due to ruptured HCC was significantly higher for those treated via
                                          TAE as compared to those who were treated conservatively (92.3% vs. 36.4%, P = 0.008).
                                          Overall median duration for which the patients remained alive after HCC rupture was longer
                                          for TAE group (39 days vs. 5 days, P = 0.03). In-hospital mortality (30.8% vs.72.7%, P = 0.04)
                                          and 30-day mortality was also lower in TAE group (38.5% vs. 90.9%, P = 0.01). Those who
                                          underwent TAE had lower risk of mortality then conservative group [odds ratio (OR) 0.25,
                                          95% confidence interval (CI) 0.07-0.90, P = 0.03). Failure to control bleeding was associated
                                          with higher 30-day mortality (OR 2.14, 95% CI 1.24-3.68, P = 0.009). Conclusion: Ruptured
                                          HCC is a life threatening complication requiring early diagnosis and treatment. TAE is an
                                          effective and well-tolerated treatment in the management of ruptured HCC.




                                                                                              Quick Response Code:
                       This is an open access article distributed under the terms of the Creative Commons Attribution-
                       NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work
            non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.


            For reprints contact: service@oaepublish.com

                        © 2016 OAE Publishing Inc.  www.oaepublish.com                                    279
   283   284   285   286   287   288   289   290   291   292   293